Johnson & Johnson will replace Chairman and CEO Alex Gorsky with another veteran company executive starting next year. The world’s biggest maker of health care products said late Thursday that Joaquin Duato will become CEO and a member of the company’s board of directors on January 3. Duato currently serves as vice chairman of Johnson & Johnson’s (J&J) executive committee, which involves working with the company’s pharmaceutical and health sectors and overseeing its global supply chain. Duato, a dual citizen of Spain and the United States, has been with Johnson & Johnson for more than 30 years, the company said. Gorsky has served as chairman and CEO since 2012 and will become executive chairman of the board. J&J reported a 73 percent jump in second-quarter profit last month, driven by strong sales growth as hospitals and other parts of the health care industry rebounded from COVID-19 pandemic slowdowns the previous …